Funding for this research was provided by:
EU/EFPIA Innovative Medicines Initiative 2 Joint Undertaking (777357)
Received: 8 February 2022
Accepted: 5 October 2022
First Online: 22 October 2022
: In this paper we report on an evaluation of patient and public involvement within RTCure. Patient/Public Research Partners (PRPs) were involved in the design and analysis of this research, and in writing this manuscript. All participants (researchers and PRPs in RTCure) were provided with information about the purpose of the evaluation. Completion and return of the surveys was voluntary for all and implied consent to participate. As this was a service evaluation, formal ethical approval was not needed for research of this kind, according to the UK Health Research Authority (ExternalRef removed).
: Not applicable.
: The authors declare that they have no competing interests.